Dr. Kelly serves as President of Payer and Provider Solutions at IQVIA, the world’s largest clinical research organization and health data science company. He oversees partnerships with provider, patient, technology, and payer organizations to advance data sharing for research and patient care using real-world evidence.
Jey is Managing Partner and co-founder of 618 Ventures, focusing on investments in biotechnology, genomics, big data, and clinical diagnostics. He supports portfolio companies in strategy, financing, and business development, with a focus on cancer and precision medicine.
Rich is Managing Partner and co-founder of 618 Ventures, leading investments in medical devices, wearables, and digital health. He holds over 25 US patents for medical devices and sensors and has spoken at global health and technology conferences.
Dr. Hsu joined 618 Ventures in 2019 as a Venture Partner and serves as Chief Medical Officer at L-Nutra, a biotechnology company specializing in cellular regeneration for human health and longevity. He advances L-Nutra’s research with global institutions and promotes its health technologies in healthcare practices.
618 Ventures contributes operational experience to its portfolio companies, offering advice, connections, and hands-on support in day-to-day business operations.
